Robert H. K. Mak

Dr. Robert H. K. Mak


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2011 in Journal of Cachexia, Sarcopenia and Muscle
Verified
Journal Article
Open access
PDF file
RMRobert H. K. Mak
Robert H. K. Mak
TITalat Alp Ikizler
Talat Alp Ikizler
CKCsaba P. Kovesdy
Csaba P. Kovesdy
DRDominic S. Raj
Dominic S. Raj
PSPeter Stenvinkel
Peter Stenvinkel
Kamyar Kalantar-ZadehKamyar Kalantar-Zadeh
Kamyar Kalantar-Zadeh
Wasting/cachexia is prevalent among patients with chronic kidney disease (CKD). It is to be distinguished from malnutrition, which is defined as the consequence of insufficient food intake or an improper diet. Malnutrition is characterized by hunger, which is an adaptive response, whereas anorexia is prevalent in patients with wasting/cachexia. Energy expenditure decreases as a protective mechanism in malnutrition whereas it remains inappropriately high in cachexia/wasting. In malnutrition, fat mass is preferentially lost and lean body mass and muscle mass is preserved. In cachexia/wasting, muscle is wasted and fat is relatively underutilized. Restoring adequate food intake or altering the composition of the diet reverses malnutrition. Nutrition supplementation does not totally reverse cachexia/wasting. The diagnostic criteria of cachexia/protein–energy wasting in CKD are considered. The association of wasting surrogates, such as serum albumin and prealbumin, with mortality is strong making them robust outcome predictors. At the patient level, longevity has consistently been observed in patients with CKD who have more muscle and/or fat, who report better appetite and who eat more. Although inadequate nutritional intake may contribute to wasting or cachexia, recent evidence indicates that other factors, including systemic inflammation, perturbations of appetite‐controlling hormones from reduced renal clearance, aberrant neuropeptide signaling, insulin and insulin‐like growth factor resistance, and metabolic acidosis, may be important in the pathogenesis of CKD‐associated wasting. A number of novel therapeutic approaches, such as ghrelin agonists and melanocortin receptor antagonists are currently at the experimental level and await confirmation by randomized controlled clinical trials in patients with CKD‐associated cachexia/wasting syndrome.

26 November 2019 in Jornal de Pediatria
Verified
Journal Article
Open access
ASAna Cristina Simões e Silva
Ana Cristina Simões e Silva
EOEduardo Oliveira
Eduardo Oliveira
RMRobert H. K. Mak
Robert H. K. Mak
This review aimed to provide a critical overview on the pathogenesis, clinical findings, diagnosis, imaging investigation, treatment, chemoprophylaxis, and complications of urinary tract infection in pediatric patients. Data were obtained independently by two authors, who carried out a comprehensive and non-systematic search in public databases. Urinary tract infection is the most common bacterial infection in children. Urinary tract infection in pediatric patients can be the early clinical manifestation of congenital anomalies of the kidney and urinary tract (CAKUT) or be related to bladder dysfunctions. E. coli is responsible for 80-90% of community-acquired acute pyelonephritis episodes, especially in children. Bacterial virulence factors and the innate host immune systems may contribute to the occurrence and severity of urinary tract infection. The clinical presentation of urinary tract infections in children is highly heterogeneous, with symptoms that can be quite obscure. Urine culture is still the gold standard for diagnosing urinary tract infection and methods of urine collection in individual centers should be determined based on the accuracy of voided specimens. The debate on the ideal imaging protocol is still ongoing and there is tendency of less use of prophylaxis. Alternative measures and management of risk factors for recurrent urinary tract infection should be emphasized. However, in selected patients, prophylaxis can protect from recurrent urinary tract infection and long-term consequences. According to population-based studies, hypertension and chronic kidney disease are rarely associated with urinary tract infection. Many aspects regarding urinary tract infection in children are still matters of debate, especially imaging investigation and indication of antibiotic prophylaxis. Further longitudinal studies are needed to establish tailored approach of urinary tract infection in childhood.

29 January 2010 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
WCWai W. Cheung
Wai W. Cheung
KPKyung Hoon Paik
Kyung Hoon Paik
RMRobert H. K. Mak
Robert H. K. Mak

6 February 2011 in Pediatric Nephrology
Verified
Journal Article
Open access
PDF file
RMRobert H. K. Mak
Robert H. K. Mak
WCWai W. Cheung
Wai W. Cheung
JZJian-Ying Zhan
Jian-Ying Zhan
QSQian Shen
Qian Shen
BFBethany J. Foster
Bethany J. Foster
Children with chronic kidney disease (CKD) are at risk for “cachexia” or “protein-energy wasting” (PEW). These terms describe a pathophysiologic process resulting in the loss of muscle, with or without loss of fat, and involving maladaptive responses, including anorexia and elevated metabolic rate. PEW has been defined specifically in relation to CKD. We review the diagnostic criteria for cachexia and PEW in CKD and consider the limitations and applicability of these criteria to children with CKD. In addition, we present an overview of the manifestations and mechanisms of cachexia and PEW. A host of pathogenetic factors are considered, including systemic inflammation, endocrine perturbations, and abnormal neuropeptide signaling, as well as poor nutritional intake. Mortality risk, which is 100- to 200-fold higher in patients with end-stage renal disease than in the general population, is strongly correlated with the components of cachexia/PEW. Further research into the causes and consequences of wasting and growth retardation is needed in order to improve the survival and quality of life for children with CKD.

8 July 2019 in Seminars in Dialysis
Verified
Journal Article
Closed access
PDF file
EOEduardo A. Oliveira
Eduardo A. Oliveira
RZRonghao Zheng
Ronghao Zheng
CCCaitlin E. Carter
Caitlin E. Carter
RMRobert H. K. Mak
Robert H. K. Mak

1 February 2008 in Growth Hormone & IGF Research
Verified
Journal Article
Closed access
RMRobert H. K. Mak
Robert H. K. Mak
WCWai W. Cheung
Wai W. Cheung
CRCharles T. Roberts
Charles T. Roberts